Crohn's Disease

After dysplasia resection in patients with inflammatory bowel disease, risk for colorectal cancer was low, according to results published in Gastrointestinal Endoscopy.

Patients with inflammatory bowel disease who received home infusions of Remicade had higher rates of nonadherence and discontinuation of the drug, according to study results.

As far as hot-button health care topics go, it is hard to top vaccines. Even dropped into a casual conversation, the idea itself in its various iterations can cause tension and divisiveness.

Entyvio yielded a lower risk for non-infectious serious adverse events than TNF antagonist therapy in Crohn’s disease, according to a study published in Alimentary Pharmacology and Therapeutics.

There are currently many new and emerging therapies treating inflammatory bowel disease.

There are many different treatments for inflammatory bowel disease, and choosing the right one for a patient with a new diagnosis can be a challenge.

Time to patient presentation was the largest component of time to diagnosis of inflammatory bowel disease, according to research published in Alimentary Pharmacology & Therapeutics.

Patients with Crohn’s disease or ulcerative colitis who underwent PCI had a lower rate of in-hospital MACCE, mortality and stroke or transient ischemic attack compared with those without inflammatory bowel disease, researchers reported.

Patients with inflammatory bowel disease were at greater risk for developing dementia, according to research published in Gut.

Healio Gastroenterology presents the following reports on the most recent research on inflammatory bowel disease.